Skip to content
Maimon Research LLC

  • Home
  • Distance Education Programs
  • Programs For Purchase
  • Working Papers
  • Questions and Answers
Latest Working Papers

IMPLEMENTING THE RARE DISEASE TEN COMMANDMENTS FOR VALUE CLAIMS, PRICING AND REIMBURSEMENT: THE WYOMING NEW START CERTIFICATE PROGRAM IN HEALTH TECHNOLOGY ASSESSMENT

January 23, 2024 Dr Paul Langely 559 Views

Paul C. Langley, Ph.D., Adjunct Professor, College of Pharmacy, University of Minnesota, Minneapolis, MN

MAIMON-WORKING-PAPERS-No.-1-JANUARY-2024Download

  • ENHANCING THE RASCH RESPONSE MODEL FOR VALUE CLAIMS: LATENT TRAIT POSSESSION AND FORMULARY EVALUATIONS [A SHORTENED VERSION OF WORKING PAPER No. 19]
  • REJECTING THE PBAC GUIDELINES FOR IMAGINARY COST-EFFECTIVENESS VALUE CLAIMS: A PROPOSED NEW START FOR HEALTH TECHNOLOGY ASSESSMENT IN AUSTRALIA

DIRECT LINKS

  • LATENT CONSTRUCTS
  • RASCH POSSESSION
  • RASCH NUMBER LINE
  • NUMERICAL STORYTELLING
  • OBJECTIVE KNOWLEDGE
  • LOGIT RATIO SCALE
  • IMPOSSIBLE QALY
  • IMPOSSIBLE REFERENCE CASE
  • VALUE CLAIMS
  • CHEERS 2022 GUIDELINE

Most Viewed Working Papers

  • CORE VALUE CLAIMS, PROTOCOLS AND FORMULARY EVALUATIONS
  • NOTHING TO CHEER ABOUT: ENDORSING IMAGINARY ECONOMIC EVALUATIONS
  • AN ORDINAL OVERSIGHT: ABANDONING THE TUFTS
  • FUNDAMENTAL MEASUREMENT AND THERAPY RESPONSE
  • VALUE CLAIMS AND THE NEW START IN RARE DISEASE
  • REJECTING PSEUDOSCIENCE: TEN COMMANDMENTS
  • EVIDENTIARY STANDARDS FOR PATIENT-CENTRIC CORE IMPACT
  • DAMAGED GOODS: IMAGINARY ICER VALUE ASSESSMENTS
  • MEASUREMENT AND RESPONSE TO THERAPY
Copyright © 2025 Maimon Research LLC. All rights reserved.
Privacy Policy